Search Results

Medline has announced the signing of a five-year primary supplier vendor agreement with St. Luke’s, headquartered in Duluth, Minnesota.

Asensus Surgical, Inc. announced that St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System in the Urology and Gastroenterology/General Surgery department.

GE HealthCare, a leading medical technology innovator, announced its largest ever CT deal in the United States – a $30 million order by St. Luke’s University Health Network, a nationally recognized nonprofit healthcare network, to install 21 of GE HealthCare’s innovative CT systems, powered by Artificial Intelligence, across their system.

Zentalis® Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, announced the appointment of Luke Walker, M.D., to its Board of Directors.

St. Luke’s Health and its academic affiliate Baylor College of Medicine are back in-network with Cigna, adding the insurer to a large group of in-network carriers.

BioLineRx Ltd. today announced a multi-center Phase 1 clinical trial sponsored by St. Jude Children’s Research Hospital, Inc. to evaluate motixafortide for the mobilization of CD34+ hematopoietic stem cells (HSCs) used in the development of gene therapies for patients with sickle cell disease (SCD).

Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that a research team from St. Michael’s Hospital, a site of Unity Health Toronto, has joined the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).